Concepedia

Wenwei Xu

WX

Statistics

Publications

10

Citations

256

H-Index

10

Active since

2011

Affiliations

Chinese Academy of Sciences(Current)

Shanghai Institute of Materia Medica

Wenzhou Medical University

University of Chinese Academy of Sciences

First Affiliated Hospital of Wenzhou Medical University

Wenwei Xu is an author at Chinese Academy of Sciences specializing in pharmacology, pharmacy, and drug discovery.

Publications per year

2011–2023

10

Publications

10

Phospho-Tyr705 of STAT3 is a therapeutic target for sepsis through regulating inflammation and coagulation

Shunyao Xu, Xiaojun Pan, Lingjie Mao et al. · Cell Communication and Signaling · 2020 · 66 citations · Full text

, , +16

Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice

Wenyi Wang, Jie Zhang, Wenyu Wu et al. · PLoS ONE · 2011 · 52 citations · Full text

, , +17

Discovery of a Novel Series of Imidazo[1,2-<i>a</i>]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A<sub>2</sub> Inhibitors

Xinde Chen, Wenwei Xu, Kai Wang et al. · Journal of Medicinal Chemistry · 2015 · 42 citations · Full text

, , +11

Inhibition of Fibroblast Growth Factor Receptor by AZD4547 Protects Against Inflammation in Septic Mice

Yueyue Huang, Fen Wang, Hao Li et al. · Inflammation · 2019 · 22 citations

, , +14

Triazole derivatives: A series of Darapladib analogues as orally active Lp-PLA2 inhibitors

Kai Wang, Wenwei Xu, Wei Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 15 citations · Full text

, , +7

1–5 of 10